Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $5.9300 (-6.1%) ($5.9250 - $5.9300) on Wed. Mar. 22, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.07% (three month average) | RSI | 34 | Latest Price | $5.9300(-6.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2.6% a day on average for past five trading days. | Weekly Trend | IOVA declines -5.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) XBI(47%) IBB(34%) ACES(25%) IWC(24%) ARKG(22%) | Factors Impacting IOVA price | IOVA will decline at least -2.035% in a week (0% probabilities). BND(-13%) XLP(-12%) UUP(-12%) VXX(-11%) VIXM(-10%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.035% (StdDev 4.07%) | Hourly BBV | -2.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-5.31(-189.54%) | Resistance Level | $6.78 | 5 Day Moving Average | $6.34(-6.47%) | 10 Day Moving Average | $6.43(-7.78%) | 20 Day Moving Average | $6.78(-12.54%) | To recent high | -28% | To recent low | 5.7% | Market Cap | $868m | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |